• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,115
3,509
3,392
2,813
2,750

COUNTRY

2,359
868
275
262
226

CATEGORIES

  • 951
  • 173
  • 114
  • 290
    • 49
  • 498
  • 259
  • 237
  • 56
  • 62
  • 839
  • 1,484
  • 821
  • 19
  • 487
  • 1,411
  • 2,353
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 267
  • 35
  • 2,588
SHOW ALL…

PRICE

5,432
9,825
21,061
28,491

PUBLISHED

2,273
6,796
12,016
28,491

PRODUCT TYPE

26,001
1,058
1,047
163
81
61
21
21
16
15
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2015 IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2015

The IL-4 signaling pathway stimulates the JAK/STAT and MAPK signaling modules. There are today 155 companies plus partners developing 191 IL-4 pathway targeting drugs in 739 developmental projects...

January 2015
FROM
Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015 Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Targeting Focal Adhesion for the Treatment of Cancer Drug Pipeline Update 2015

Cell-matrix adhesions play essential roles in important biological processes including cell motility, cell proliferation, cell differentiation, regulation of gene expression and cell survival. At the...

January 2015
FROM
Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015 Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Targeting Cell Adhesion Molecules (CAMs) for the Treatment of Cancer Drug Pipeline Update 2015

Cell adhesion molecules are (glyco)proteins expressed on the cell surface and play a critical role in a wide array of biologic processes that include hemostasis, the immune response, inflammation, embryogenesis,...

January 2015
FROM
Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015 Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Toll-Like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

Specific families of pattern recognition receptors are responsible for detecting microbial pathogens and generating innate immune responses. Toll-like receptors (TLRs) are membrane-bound receptors identified...

January 2015
FROM
Bio-Europe 2014 Cancer Drug Pipeline Update 2015 Bio-Europe 2014 Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Bio-Europe 2014 Cancer Drug Pipeline Update 2015

BIO-Europe 2014 (3rd to 5th November) is Europe's largest biotech partnering conference and is of huge significance for the oncology industry. In fact, the author can reveal that companies participating...

January 2015
FROM
Colorectal Cancer Drug Pipeline Update 2015 Colorectal Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

Colorectal Cancer Drug Pipeline Update 2015

Until a decade ago, 5FU/leucovorin formed the mainstay of colorectal cancer treatment but Camptosar and Eloxatin quickly established themselves as components of gold-standard therapy. The advent of...

January 2015
FROM
Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Androgen Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

The androgen receptor signaling pathway activates the SMAD signaling module. There are today 343 companies plus partners developing 401 Androgen Receptor drugs in 1537 developmental projects in cancer....

January 2015
FROM
IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2015 IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

IL-2 Signaling Pathway in Oncology Drug Pipeline Update 2015

The IL-2 signaling pathway activates the Ras/MAPK, JAK/Stat and PI 3-kinase/Akt signaling modules. There are today 257 companies plus partners developing 322 IL-2 pathway targeting drugs in 1341 developmental...

January 2015
FROM
T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

T Cell Receptor Signaling Pathway in Oncology Drug Pipeline Update 2015

Stimulation of the T cell receptor leads to the activation of NFkB and NFAT signaling modules which play a key role in T cell receptor signaling. There are today 261 companies plus partners developing...

January 2015
FROM
RANKL Signaling Pathway in Oncology Drug Pipeline Update 2015 RANKL Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

RANKL Signaling Pathway in Oncology Drug Pipeline Update 2015

Receptor activator of nuclear factor-kappa B ligand (RANKL) is a member of tumor necrosis factor (TNF) superfamily. It binds to Receptor activator of NF-kB (RANK) and plays a major role in the regulation...

January 2015
FROM
TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015 TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

TSLP Signaling Pathway in Oncology Drug Pipeline Update 2015

Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine that play various roles in a broad spectrum of biological procedures. TSLP can be secreted by epithelial cells upon pathogen stimulation....

January 2015
FROM
PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2015 PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2015

The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation,...

January 2015
FROM
The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2015 The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2015

The mitogen-activated protein kinase (MAPK) cascade is a highly conserved module that is involved in various cellular functions, including cell proliferation, differentiation and migration. There are...

January 2015
FROM
RIG-I-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015 RIG-I-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015 - Product Thumbnail Image

RIG-I-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2015

Specific families of pattern recognition receptors are responsible for detecting viral pathogens and generating innate immune responses. Non-self RNA appearing in a cell as a result of intracellular...

January 2015
FROM
The Latest Sales Figures in Oncology Drug Pipeline Update 2015 The Latest Sales Figures in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

The Latest Sales Figures in Oncology Drug Pipeline Update 2015

The Latest Sales Figures in Oncology brings together up to 5 years of sales data on top 70+ cancer drugs by country/region from both global pharmacuetical companies to progressive biotech companies....

January 2015
FROM
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2015 Nucleic Acid Therapies in Oncology Drug Pipeline Update 2015 - Product Thumbnail Image

Nucleic Acid Therapies in Oncology Drug Pipeline Update 2015

Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today...

January 2015
FROM
Cancer Stem Cells Drug Pipeline Update 2015 Cancer Stem Cells Drug Pipeline Update 2015 - Product Thumbnail Image

Cancer Stem Cells Drug Pipeline Update 2015

Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs...

January 2015
FROM
Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies - Product Thumbnail Image

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies

Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics,...

January 2015

Anti Dermatomycosis Skin Drugs Markets in China

China's demand for Anti Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high...

January 2015
FROM

Anti Peptic Ulcer Drugs Markets in China

China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed...

January 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S